SectorBiological Technology
Established Date--
Listing Date25/09/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees17
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1900 Lake Park Drive, Suite 380, Smyrna, GA 30080
Business
IntroductionGeoVax Labs, Inc., was established in June 1988. The company is a clinical-stage biotechnology company that develops immunotherapies and vaccines against cancer and infectious diseases using a novel vector vaccine platform (modified vaccinia Ankara virus-like particles or "GV-MVA-VLPTM "). The company's current development plans focus on preventive and therapeutic vaccines against human immunodeficiency virus (HIV); preventive vaccines against hemorrhagic fever virus (Ebola, Sudan, Marburg and Lhasa), Zika virus and malaria; therapeutic vaccines for chronic hepatitis B virus infection and immunotherapy against solid tumor cancer.
